Anti-MMP-25 Rabbit Polyclonal Antibody

Rabbit Polyclonal
WB
Citation tracking pending
Rabbit polyclonal antibodies targeting MMP-25 (leukolysin, membrane-type-6 matrix metalloproteinase), validated for Western blot.
Host
Rabbit, Polyclonal
Reactivity
Validated- Human Potential-Pan, Monkey
UniProt
Q9NPA2
Size
100ug
Cat. #
RP1MMP25

In stock

SKU
RP-MMP25

Options

As low as: $130.00

Target Overview

Matrix metalloproteinase-25 (MMP-25, UniProt Q9NPA2) is a membrane-anchored member of the matrix metalloproteinase family, classified as membrane-type matrix metalloproteinase 6 (MT6-MMP). The 562-amino acid protein functions as a zinc-dependent endopeptidase (EC 3.4.24.-) and is alternatively designated leukolysin based on its expression in leukocytes. MMP-25 localizes to the cell membrane where it may activate progelatinase A (MMP-2), contributing to extracellular matrix remodeling. Unlike several other MT-MMPs, MMP-25 exhibits a more restricted tissue distribution, with notable expression in peripheral blood leukocytes and activated neutrophils. The enzyme contains a catalytic domain, hinge region, and transmembrane domain characteristic of membrane-type MMPs. Researchers study MMP-25 in contexts ranging from inflammatory disease and tissue remodeling to cardiovascular pathology and fibrotic processes.

Background

MMP-25 participates in extracellular matrix degradation through both direct proteolytic activity and activation of other matrix metalloproteinases. Its membrane-tethered localization enables pericellular proteolysis, particularly during leukocyte migration and tissue infiltration. Recent work has implicated MMP-25 in multiple pathological processes: San Sebastian-Jaraba et al. (2026) demonstrated that MMP-25 promotes abdominal aortic aneurysm formation and atherosclerosis, establishing cardiovascular relevance for this MT-MMP family member. In fibrotic disease, Wang et al. (2026) identified MMP-25 as a transcriptional target of NR5A2 that promotes epithelial-to-mesenchymal transition in renal fibrosis, suggesting a role in chronic kidney disease progression. Inflammatory contexts have emerged as particularly important for MMP-25 function. Wu et al. (2026) validated MMP-25 as a pro-inflammatory mediator in osteoarthritis through combined bioinformatic and functional approaches, while Zou et al. (2026) found differential regulation of MMP-25 expression during exercise-mediated neuroprotection in cerebral ischemia-reperfusion injury, linking the proteinase to neutrophil infiltration and blood-brain barrier disruption. The enzyme has also been identified in gene expression signatures associated with immune-mediated diseases, including IVIG-unresponsive Kawasaki disease. Triple Point Biologics has developed five rabbit polyclonal antibodies targeting the hinge region of MMP-25, validated for Western blot applications. These reagents enable detection of MMP-25 in human samples, with predicted cross-reactivity in primate tissues. The antibodies are suitable for investigating MMP-25 expression and localization across inflammatory, cardiovascular, and fibrotic disease models.

References

  1. San Sebastian-Jaraba I et al (2026) Metalloproteinase 25 promotes abdominal aortic aneurysm and atherosclerosis. Atherosclerosis. PubMed · doi:10.1016/j.atherosclerosis.2026.120676
  2. Wu T et al (2026) From bioinformatic identification to functional validation: MMP25 as a pro-inflammatory mediator in osteoarthritis. J Orthop Surg Res. PubMed · doi:10.1186/s13018-026-06732-4
  3. Wang X et al (2026) NR5A2 promotes epithelial-to-mesenchymal transition in renal fibrosis by targeting MMP25 transcription. Biochim Biophys Acta Mol Basis Dis. PubMed · doi:10.1016/j.bbadis.2025.168121
  4. Zou M et al (2026) Forced and voluntary exercise exert differential neuroprotective effects in cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and blood-brain barrier disruption. Brain Res Bull. PubMed · doi:10.1016/j.brainresbull.2025.111668
  5. Zhao ZH et al (2026) Expression of key genes in IVIG-unresponsive Kawasaki disease and their immune correlation based on bioinformatics analysis. Immunol Res. PubMed · doi:10.1007/s12026-026-09746-6

Additional Specifications

Gene Symbol MMP25
UniProt ID Q9NPA2
Host Species Rabbit
Species Reactivity Validated- Human
Potential-Pan, Monkey
Pack Size 100ug
Immunogen (Hinge region)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 278-313.
Immunogen (Carboxy end Hemopexin Domain)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 339-539.
Immunogen (Aminoterminal end active form)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 108-158.
Immunogen (Propeptide domain MMP-25)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 22-107.
Immunogen (Carboxyterminal end)Immunogen is proprietary and confidential. Immunogen generated in amino acid region 489-539.
Alternate Names Matrix metalloproteinase-25, MMP-25, MMP25, Leukolysin, Membrane-type matrix metalloproteinase 6, MT-MMP 6, MTMMP6, Membrane-type-6 matrix metalloproteinase, MT6-MMP, MT6MMP, EC 3.4.24.-

Frequently Asked Questions

What molecular weight should I expect for MMP-25 on a Western blot?

MMP-25 migrates at approximately 63 kDa on reducing SDS-PAGE, corresponding to the full-length 562-amino acid protein including its signal peptide, prodomain, catalytic domain, hinge region, and transmembrane domain. Some labs observe additional bands around 54 kDa representing the activated form after prodomain cleavage. Because MMP-25 is a membrane-anchored proteinase, you may also detect high-molecular-weight species if the protein remains in oligomeric complexes or associated with other membrane proteins. Glycosylation can shift the apparent mass slightly depending on cell type and post-translational modification status.

What is the recommended starting dilution for MMP-25 antibody in Western blot?

We recommend starting at 1:1000 dilution in blocking buffer for Western blot applications with this rabbit polyclonal MMP-25 antibody. This dilution has been validated with human lysates. Depending on MMP-25 expression levels in your sample, you may need to titrate between 1:500 and 1:2000 to optimize signal and minimize background. Leukocyte and activated neutrophil lysates typically yield robust signal at 1:1000, whereas samples from tissues with lower endogenous MMP-25 expression may require a more concentrated antibody. Include a positive control lysate from peripheral blood leukocytes to benchmark sensitivity in your system.

Is this MMP-25 antibody validated for monkey or mouse samples?

This antibody is validated for human MMP-25 and shows predicted cross-reactivity with monkey (non-human primate) samples based on sequence homology in the immunogen region. We have not formally validated reactivity in mouse, rat, or other rodent species. Human and cynomolgus monkey MMP-25 share high sequence identity in the catalytic and hinge domains, so the antibody should recognize primate orthologs. If you are working with mouse samples, we recommend running a positive human control in parallel and verifying any bands by siRNA knockdown or peptide competition, as cross-species reactivity is not guaranteed.

What sample preparation works best for detecting membrane-bound MMP-25?

Because MMP-25 is a membrane-type MMP with a transmembrane domain, use lysis buffers containing non-ionic detergents such as 1% Triton X-100, 1% NP-40, or RIPA buffer to solubilize membrane proteins effectively. Avoid harsh ionic detergents like SDS during lysis, as they can denature the epitope. For Western blot, load 20–50 µg total protein per lane; leukocyte-enriched samples or activated neutrophil lysates provide the best positive controls given MMP-25's restricted tissue distribution. If signal is weak in whole-cell lysates, consider enriching the membrane fraction by ultracentrifugation to concentrate MMP-25 away from cytosolic contaminants.

Does MMP-25 have splice isoforms I need to account for?

MMP-25 is encoded by a single gene on chromosome 16 and does not have well-characterized splice isoforms reported in major databases. The canonical 562-amino acid isoform is the predominant form expressed in leukocytes. You may observe proteolytic processing variants on Western blot: the inactive zymogen (~63 kDa) and the activated form after furin-mediated or autocatalytic cleavage of the prodomain (~54 kDa). Unlike some other MMPs with secreted and membrane-bound splice variants, MMP-25 remains anchored to the membrane via its C-terminal transmembrane domain in all reported functional studies, so focus on membrane-enriched fractions for optimal detection.

Can I use this antibody for immunohistochemistry on human tissue sections?

Yes, Triple Point Biologics antibodies are validated for immunohistochemistry applications, and this rabbit polyclonal should work on formalin-fixed paraffin-embedded or frozen human tissue sections. For IHC, start with a 1:100 to 1:200 dilution and perform antigen retrieval using citrate buffer (pH 6.0) or Tris-EDTA (pH 9.0) for FFPE sections to unmask epitopes. MMP-25 expression is highest in leukocyte-rich tissues such as spleen, lymph node, and inflamed tissues with neutrophil infiltration. Include a known MMP-25-positive tissue control and a no-primary-antibody negative control to validate staining specificity in your hands.

What are the best positive and negative controls for MMP-25 experiments?

For positive controls, use lysates from peripheral blood leukocytes, activated human neutrophils, or differentiated myeloid cell lines such as HL-60 or THP-1 cells treated with PMA to induce MMP-25 expression. These cell types exhibit robust endogenous MMP-25 levels. Negative controls should include tissues or cell lines with minimal MMP-25 expression, such as most epithelial cell lines or fibroblasts. For antibody specificity controls, consider siRNA knockdown of MMP-25 in a positive cell line or peptide competition with the immunogen if available. Running samples with and without reducing agent can also help confirm the monomeric membrane-bound form.

How should I store the MMP-25 antibody and what is its shelf life?

Store the antibody at –20°C in small aliquots to avoid repeated freeze-thaw cycles, which can reduce titer and increase aggregation. The 100 µg pack size is suitable for dividing into 10–20 µL working aliquots upon receipt. Once thawed, an aliquot can be kept at 4°C for up to one month if supplemented with 0.02% sodium azide as a preservative, though we recommend single-use aliquots for most consistent results. Typical shelf life is two years from manufacture date when stored properly at –20°C. Avoid prolonged exposure to room temperature and never refreeze a thawed aliquot multiple times.

Western blot validation for RP-MMP25 — 2 panels across the domain-specific antibody variants. Each blot below shows the clone that validates a specific domain of the target protein.

MMP-25: Hinge region — WB validation
WB · Panel 1 MMP-25: Hinge region
MMP-25: Propeptide domain MMP-25 — WB validation
WB · Panel 2 MMP-25: Propeptide domain MMP-25

Custom validation studies available on request — contact us.

Also known as:

  • Matrix metalloproteinase-25
  • MMP-25
  • MMP25
  • Leukolysin
  • Membrane-type matrix metalloproteinase 6
  • MT-MMP 6
  • MTMMP6
  • Membrane-type-6 matrix metalloproteinase
  • MT6-MMP
  • MT6MMP
  • EC 3.4.24.-
  • Product Datasheet

    Full specifications, immunogen, validation, and recommended protocols.

    Request PDF →
  • Certificate of Analysis (COA)

    Lot-specific QC report. Available on request for any catalog lot.

    Request COA →
  • Safety Data Sheet (SDS)

    Handling, storage, and disposal guidance per regulatory standards.

    Request SDS →